Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05266105 |
| Title | A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Olema Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Site 6108 | Waratah | New South Wales | 2298 | Australia | Details | |
| Site 6104 | Westmead | New South Wales | 2145 | Australia | Details | |
| Site 6102 | South Brisbane | Queensland | 4101 | Australia | Details | |
| Site 6109 | Southport | Queensland | 4215 | Australia | Details | |
| Site 6101 | Clayton | Victoria | 3168 | Australia | Details | |
| Site 6106 | Frankston | Victoria | 3199 | Australia | Details | |
| Site 6103 | Geelong | Victoria | 3220 | Australia | Details | |
| Site 6105 | Nedlands | Western Australia | 6009 | Australia | Details |